Copaiba oil: An alternative to development of new drugs against leishmaniasis

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Nakamura, Celso Vataru ^a   Dos Santos, Adriana Oliveira ^a   Ueda Nakamura, Tânia ^b   Dias Filho, Benedito Prado ^a   Da Veiga Junior, Valdir Florêncio ^c  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

^c FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; COPAIBA OIL; UNCLASSIFIED DRUG;

AMASTIGOTE; ARTICLE; CELL DAMAGE; CELL MEMBRANE; CELL ORGANELLE; CELL VIABILITY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; LEISHMANIA; LEISHMANIASIS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SCANNING ELECTRON MICROSCOPY;

EID: 80052671817     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/898419     Document Type: Article

References (34)

1. Boelaert M., Criel B., Leeuwenburg J., Van Damme W., Le Ray D., Van Der Stuyft P., Visceral leishmaniasis control: a public health perspective Transactions of the Royal Society of Tropical Medicine and Hygiene 2000 94 5 465 471
2. Murray H. W., Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches International Journal of Infectious Diseases 2000 4 3 158 177
3. Murray H. W., Berman J. D., Davies C. R., Saravia N. G., Advances in leishmaniasis Lancet 2005 366 9496 1561 1577 (Pubitemid 41540115)
4. Amato V. S., Tuon F. F., Bacha H. A., Amato Neto V., Nicodemo A. C., Mucosal leishmaniasis. Current scenario and prospects for treatment Acta Tropica 2008 105 1 1 9 (Pubitemid 350262798)
5. Clem A., A current perspective on leishmaniasis Journal of Global Infectious Diseases 2010 2 124 126
6. Desjeux P., Leishmaniasis: current situation and new perspectives Comparative Immunology, Microbiology and Infectious Diseases 2004 27 5 305 318 (Pubitemid 38842803)
7. World Health Organization, Urbanization: an increasing risk factor for leishmaniasis Weekly Epidemiological Record 2002 77 44 365 370
8. Marlet M. V. L., Sang D. K., Ritmeijer K., Muga R. O., Onsongo J., Davidson R. N., Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, northeastern Kenya, and south-eastern Ethiopia in 2000-2001 Transactions of the Royal Society of Tropical Medicine and Hygiene 2003 97 5 515 518 (Pubitemid 40590082)
9. Reithinger R., Dujardin J. C., Louzir H., Pirmez C., Alexander B., Brooker S., Cutaneous leishmaniasis Lancet Infectious Diseases 2007 7 9 581 596 (Pubitemid 47277438)
10. Sharlow E. R., Grgl M., Johnson J., Lazo J. S., Anti-leishmanial drug discovery: rising to the challenges of a highly neglected disease Molecular Interventions 2010 10 2 72 75
11. Gluenz E., Ginger M. L., McKean P. G., Flagellum assembly and function during the Leishmania life cycle Current Opinion in Microbiology 2010 13 1 7
12. Cunningham A. C., Parasitic adaptive mechanisms in infection by Leishmania Experimental and Molecular Pathology 2002 72 2 132 141
13. Kima P. E., The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist International Journal for Parasitology 2007 37 10 1087 1096 (Pubitemid 47042032)
14. Trouiller P., Olliaro P., Torreele E., Orbinski J., Laing R., Ford N., Drug development for neglected diseases: a deficient market and a public-health policy failure Lancet 2002 359 9324 2188 2194 (Pubitemid 34694030)
15. Palumbo E., Oral miltefosine treatment in children with visceral leishmaniasis: a brief review Brazilian Journal of Infectious Diseases 2008 12 1 2 4
16. Rates S. M. K., Plants as source of drugs Toxicon 2001 39 5 603 613
17. Anthony J. P., Fyfe L., Smith H., Plant active componentsa resource for antiparasitic agents? Trends in Parasitology 2005 21 10 462 468 (Pubitemid 41297749)
18. Wang J., Peng Q., Li G., New compounds of natural resources in 2008 African Journal of Biotechnology 2009 8 18 4299 4307
19. Brando M. G., Zanetti N. N., Oliveira P., Grael C. F., Santos A. C., Monte-Mr R. L., Brazilian medicinal plants described by 19th century European naturalists and in the Official Pharmacopoeia Journal of Ethnopharmacology 2008 20 2 141 148
20. Veiga-Junior V. F., Pinto A. C., The Copaifera L. Genus Quim Nova 2001 25 273 286
21. Grenand P., Moretti C., Pharmacopées Traditionnelles en Guyane. Créoles, Palikur, Waypi 1987 France, Paris Orstom
22. Fleury M., A propos de l'intért médicinal du baume de Copahu Acta Botanica Gallica 1997 144 4 473 479 (Pubitemid 127615028)
23. Moreira R. C., Rebelo J. M., Gama M. E., Costa J. M., knowledge level about of American tegumentary leishmaniasis (ATL) and use of alternative therapies in an endemic area in the Amazon Region in the State of Maranho, Brazil Cadernos de Saude Publica 2002 18 1 187 195
24. Kvist L. P., Christensen S. B., Rasmussen H. B., Mejia K., Gonzalez A., Identification and evaluation of Peruvian plants used to treat malaria and leishmaniasis Journal of Ethnopharmacology 2006 106 3 390 402
25. Santos A. O., Ueda-Nakamura T., Dias Filho B. P., Veiga-Junior V. F., Pinto A. C., Nakamura C. V., Effect of Brazilian copaiba oils on Leishmania amazonensis Journal of Ethnopharmacology 2008 120 2 204 208
26. Ueda-Nakamura T., Attias M., Souza W., Megasome biogenesis in Leishmania amazonensis: a morphometric and cytochemical study Parasitology Research 2001 87 2 89 97 (Pubitemid 32208945)
27. Fernandes F. F., Freitas E. P. S., Acaricidal activity of an oleoresinous extract from Copaifera reticulata (Leguminosae: Caesalpinioideae) against larvae of the southern cattle tick, Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) Veterinary Parasitology 2007 147 1-2 150 154
28. Lima S. R. M., Veiga-Junior V. F., Christo H. B., Pinto A. C., Fernandes P. D., In vivo and in vitro studies on the anticancer activity of Copaifera multijuga Hayne and its fractions Phytotherapy Research 2003 17 9 1048 1053 (Pubitemid 37351578)
29. Souza W., Structural organization of the cell surface of pathogenic protozoa Micron 1995 26 5 405 430
30. McConville M. J., Ralton J. E., Developmentally regulated changes in the cell surface architecture of Leishmania parasites Behring Institute Mitteilungen 1997 99 34 43
31. Naderer T., Vince J. E., McConville M. J., Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host Current Molecular Medicine 2004 4 6 649 665 (Pubitemid 39172369)
32. Sen N., Das B. B., Ganguly A., Mukherjee T., Tripathi G., Bandyopadhyay S., Rakshit S., Sen T., Majumder H. K., Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani Cell Death and Differentiation 2004 11 8 924 936 (Pubitemid 39139751)
33. Sen R., Bandyopadhyay S., Dutta A., Mandal G., Ganguly S., Saha P., Chatterjee M., Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes Journal of Medical Microbiology 2007 56 9 1213 1218 (Pubitemid 47477194)
34. Roy A., Ganguly A., BoseDasgupta S., Das B. B., Pal C., Jaisankar P., Majumder H. K., Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani Molecular Pharmacology 2008 74 5 1292 1307